Use of novel oral anticoagulants for the treatment of venous thromboembolism and its considerations in Asian patients

References

• KearonCAklEAComerotaAJAmerican College of Chest PhysiciansAntithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice GuidelinesChest2012141Suppl 2e419Se494S22315268
   PubMed Web of Science ®Google Scholar
• National Clinical Guideline Centre (UK)Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing [webpage on the Internet]2012 Available from: http://www.nice.org.uk/guidance/CG144/chapter/introductionAccessed September 10, 2014
   Google Scholar
• WhiteRHZhouHRomanoPSIncidence of symptomatic venous thromboembolism after different elective or urgent surgical proceduresThromb Haemost200390344645512958614
   PubMed Web of Science ®Google Scholar
• GouldMKGarciaDAWrenSMAmerican College of Chest PhysiciansPrevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice GuidelinesChest2012141Suppl 2e227Se277S22315263
   PubMed Web of Science ®Google Scholar
• KahnSRLimWDunnASAmerican College of Chest PhysiciansPrevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice GuidelinesChest2012141Suppl 2e195Se226S22315261
   PubMed Web of Science ®Google Scholar
• SilversteinMDHeitJAMohrDNPettersonTMO’FallonWMMeltonLJ3rdTrends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based studyArch Intern Med199815865855939521222
   PubMed Web of Science ®Google Scholar
• LiaoSWoulfeTHyderSMerrimanESimpsonDChunilalSIncidence of venous thromboembolism in different ethnic groups: a regional direct comparison studyJ Thromb Haemost201412221421924283769
   PubMed Web of Science ®Google Scholar
• CohenAChiuKMParkKManaging venous thromboembolism in Asia: winds of change in the era of new oral anticoagulantsThromb Res2012130329130122766512
   PubMed Web of Science ®Google Scholar
• NakamuraMMiyataTOzekiYCurrent venous thromboembolism management and outcomes in JapanCirc J201478370871724401573
   PubMed Web of Science ®Google Scholar
• TagalakisVPatenaudeVKahnSRSuissaSIncidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study CohortAm J Med20131269832.e13e2123830539
   PubMed Web of Science ®Google Scholar
• de FranciscisSAgusGBBisacciRGuidelines for venous thromboembolism and clinical practice in Italy: a nationwide surveyAnn Vasc Surg200822331932718466813
   PubMed Web of Science ®Google Scholar
• TorbickiAPerrierAKonstantinidesSESC Committee for Practice Guidelines (CPG)Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)Eur Heart J200829182276231518757870
   PubMed Web of Science ®Google Scholar
• SerraRde FranciscisSThe role of thrombolysis for patients with hemodynamically stable acute pulmonary embolismThromb Res201413417824814971
   PubMed Web of Science ®Google Scholar
• SanchezOTrinquartLColombetIPrognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic reviewEur Heart J200829121569157718495689
   PubMed Web of Science ®Google Scholar
• WhitlonDSSadowskiJASuttieJWMechanism of coumarin action: significance of vitamin K eposide reductase inhibitionBiochemistry197817813711377646989
   PubMed Web of Science ®Google Scholar
• YamaguchiTJapanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study GroupOptimal intensity of warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation: a multicenter, prospective, randomized trialStroke200031481782110753981
   PubMed Web of Science ®Google Scholar
• YouJHChanFWWongRSChengGIs INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation?Br J Clin Pharmacol200559558258715842557
   PubMed Web of Science ®Google Scholar
• EisertWGHauelNStangierJWienenWClemensAvan RynJDabigatran: an oral novel potent reversible nonpeptide inhibitor of thrombinArterioscler Thromb Vasc Biol201030101885188920671233
   PubMed Web of Science ®Google Scholar
• AhrensILipGYPeterKNew oral anticoagulant drugs in cardiovascular diseaseThromb Haemost20101041496020539909
   PubMed Web of Science ®Google Scholar
• WangYBajorekBNew oral anticoagulants in practice: pharmacological and practical considerationsAm J Cardiovasc Drugs201414317518924452600
   PubMed Web of Science ®Google Scholar
• Academy of Medicine, Malaysia, Ministry of Health Malaysia, National Heart Association of MalaysiaClinical Practice Guidelines: Management of Venous Thromboembolism2003 Available from: www.acadmed.org.my/view_file.cfm?fileid=278Accessed September 10, 2014
   Google Scholar
• NakamuraMJapanese guidelines for prevention of venous thromboembolismJ Japan Soc Clin Anesth2004249480487
   Google Scholar
• ParakhRKakkarVVKakkarAKManagement of venous thromboembolismJ Assoc Physicians India200755497017444345
   PubMedGoogle Scholar
• Chinese Orthopaedic AssociationPrevention of venous thromboembolism after major orthopaedic surgeryOrthop Surg201022818522009920
   PubMedGoogle Scholar
• BangSMJangMJKimKHPrevention of venous thromboembolism, 2nd edition: Korean Society of Thrombosis and Hemostasis Evidence-based Clinical Practice GuidelinesJ Korean Med Sci201429216417124550640
   PubMed Web of Science ®Google Scholar
• SchulmanSKearonCKakkarAKRE-COVER Study GroupDabigatran versus warfarin in the treatment of acute venous thromboembolismN Engl J Med2009361242342235219966341
   PubMed Web of Science ®Google Scholar
• SchulmanSKakkarAKGoldhaberSZRE-COVER II Trial InvestigatorsTreatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysisCirculation2014129776477224344086
   PubMed Web of Science ®Google Scholar
• EINSTEIN InvestigatorsBauersachsRBerkowitzSDBrennerBOral rivaroxaban for symptomatic venous thromboembolismN Engl J Med2010363262499251021128814
   PubMed Web of Science ®Google Scholar
• EINSTEIN–PE InvestigatorsBüllerHRPrinsMHLensinAWOral rivaroxaban for the treatment of symptomatic pulmonary embolismN Engl J Med2012366141287129722449293
   PubMed Web of Science ®Google Scholar
• AgnelliGBullerHRCohenAAMPLIFY InvestigatorsOral apixaban for the treatment of acute venous thromboembolismN Engl J Med2013369979980823808982
   PubMed Web of Science ®Google Scholar
• Hokusai-VTE InvestigatorsBüllerHRDécoususHGrossoMAEdoxaban versus warfarin for the treatment of symptomatic venous thromboembolismN Engl J Med2013369151406141523991658
   PubMed Web of Science ®Google Scholar
• PrinsMHLensingAWBauersachsREINSTEIN InvestigatorsOral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studiesThromb J20131112124053656
   PubMedGoogle Scholar
• WangYWangCChenZChinese EINSTEIN InvestigatorsRivaroxaban for the treatment of symptomatic deep-vein thrombosis and pulmonary embolism in Chinese patients: a subgroup analysis of the EINSTEIN DVT and PE studiesThromb J20131112524341332
   PubMedGoogle Scholar
• GiuglianoRPRuffCTBraunwaldEENGAGE AF-TIMI 48 InvestigatorsEdoxaban versus warfarin in patients with atrial fibrillationN Engl J Med2013369222093210424251359
   PubMed Web of Science ®Google Scholar
• SchulmanSKearonCKakkarAKRE-MEDY Trial InvestigatorsRE-SONATE Trial InvestigatorsExtended use of dabigatran, warfarin, or placebo in venous thromboembolismN Engl J Med2013368870971823425163
   PubMed Web of Science ®Google Scholar
• AgnelliGBullerHRCohenAPLIFY-EXT InvestigatorsApixaban for extended treatment of venous thromboembolismN Engl J Med2013368869970823216615
   PubMed Web of Science ®Google Scholar
• ConnollySJEikelboomJJoynerCAVERROES Steering Committee and InvestigatorsApixaban in patients with atrial fibrillationN Engl J Med2011364980681721309657
   PubMed Web of Science ®Google Scholar
• GrangerCBAlexanderJHMcMurrayJJARISTOTLE Committees and InvestigatorsApixaban versus warfarin in patients with atrial fibrillationN Engl J Med20113651198199221870978
   PubMed Web of Science ®Google Scholar
• WHO Expert ConsultationAppropriate body-mass index for Asian populations and its implications for policy and intervention strategiesLancet2004363940315716314726171
   PubMed Web of Science ®Google Scholar
• WallaceJLReavesABTolleyEAComparison of initial warfarin response in obese patients versus non-obese patientsJ Thromb Thrombolysis20133619610123015280
   PubMed Web of Science ®Google Scholar
• LopesRDAlexanderJHAl-KhatibSMARISTOTLE InvestigatorsApixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial: design and rationaleAm Heart J2010159333133920211292
   PubMed Web of Science ®Google Scholar
• HoriMMatsumotoMTanahashiNJ-ROCKET AF study investigatorsRivaroxaban vs Warfarin in Japanese Patients with Atrial Fibrillation: the J-ROCKET AF studyCirc J20127692104211122664783
   PubMed Web of Science ®Google Scholar
• TanigawaTKanekoMHashizumeKModel-based dose selection for phase III rivaroxaban study in Japanese patients with non-valvular atrial fibrillationDrug Metab Pharmacokinet2013281597022813718
   PubMed Web of Science ®Google Scholar
• KanekoMTanigawaTHashizumeKKajikawaMTajiriMMueckWConfirmation of model-based dose selection for a Japanese phase III study of rivaroxaban in non-valvular atrial fibrillation patientsDrug Metab Pharmacokinet201328432133123337693
   PubMed Web of Science ®Google Scholar
• Pradaxa® (dabigatran etexilate)Summary of Product Characteristics20131 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000829/WC500041059.pdfAccessed September 10, 2014
   Google Scholar
• BroussalisEAnnaWTrinkaEMutzenbachSKillerMLatest developments in anticoagulant drug discoveryDrug Discov Today201419792193524607728
   PubMed Web of Science ®Google Scholar
• SakonMNakamuraMDarexaban (YM150) prevents venous thromboembolism in Japanese patients undergoing major abdominal surgery: phase III randomized, mechanical prophylaxis-controlled, open-label studyThromb Res20121303e52e5922762942
   PubMed Web of Science ®Google Scholar
• CohenATHarringtonRGoldhaberSZThe design and rationale for the Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban (APEX) studyAm Heart J2014167333534124576517
   PubMed Web of Science ®Google Scholar
• Drugstore.com [homepage on the Internet]Bellevuedrugstore.com, Inc.c1999 –2014 Available from: http://www.drugstore.comAccessed September 10, 2014
   Google Scholar
• LefebvrePColemanCIBookhartBKCost-effectiveness of rivaroxaban compared with enoxaparin plus a vitamin K antagonist for the treatment of venous thromboembolismJ Med Econ2014171526424156243
   PubMedGoogle Scholar